Transchem Peer Comparison

NSE: TRANSCHEM | BSE: 500422

₹413.50

₹-5.60 (-1.34%)

As on 08-Nov-2026IST

Market cap

₹506 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

62.7

P/B Ratio

2.5

Div. Yield

0 %

Edit

	Transchem	Piramal Pharma	Wockhardt	Acutaas Chemicals	Rubicon Research
Market cap (₹ Cr)	506	32,758	32,619	32,170	28,669
Revenue (₹ Cr)	--	9,779	3,751	1,593	2,100
Net Profit (₹ Cr)	8.07	-270.51	405.00	438.64	324.79
Net Margin (%)	53.71	-2.71	10.48	27.16	15.36
RoE (%)	5.61	-2.55	7.91	25.02	24.02
Price to Earnings	62.72	--	79.56	73.25	88.26
Price-To-Book	2.48	4.02	6.32	17.32	20.24

Income Statement (₹ Cr)

	Transchem	Piramal Pharma	Wockhardt	Acutaas Chemicals	Rubicon Research
Operating Revenue	0.00	9,778.62	3,751.00	1,592.52	2,100.17
Total Income	15.03	9,993.26	3,863.00	1,615.23	2,114.53
Total Expenditure	4.39	8,578.44	2,984.00	969.32	1,600.14
EBITDA	-4.39	1,200.18	767.00	623.20	500.03
Depreciation	0.11	887.82	228.00	41.96	57.00
EBIT	-4.51	312.36	539.00	581.24	443.03
Interest	0.02	347.94	218.00	4.21	40.83
Other Income	15.03	214.64	112.00	22.71	14.37
Exceptional Items	0.00	-216.88	12.00	0.00	0.00
Profit before Tax	10.50	-37.82	445.00	599.74	416.57
Provision for Tax	2.43	232.69	40.00	161.10	91.78
Profit after Tax	8.07	-270.51	405.00	438.64	324.79

	Transchem	Piramal Pharma	Wockhardt	Acutaas Chemicals	Rubicon Research
Shareholder's Funds	204.32	8,142.24	5,158.00	1,857.45	1,416.33
Minority Interest	0.00	0.55	5.00	0.51	0.05
Non-Current Liabilities	0.34	5,213.99	1,617.00	47.15	376.76
Current Liabilities	1.01	5,158.51	1,785.00	253.37	952.98
Total Liabilities	87.73	17,723.32	8,578.00	1,983.96	2,326.71

	Transchem	Piramal Pharma	Wockhardt	Acutaas Chemicals	Rubicon Research
Non-Current Assets	26.36	10,687.30	5,527.00	1,132.12	798.30
Current Assets	179.27	7,253.65	2,764.00	1,012.00	1,747.21
Total Assets	87.73	17,723.32	8,578.00	1,983.96	2,326.71
Total Debt*	0.00	5,495.48	2,125.00	26.49	259.37
Net Current Assets	178.26	2,095.14	979.00	758.64	794.23
Contingent Liabilities	--	95.72	768.26	17.25	19.09

	Transchem	Piramal Pharma	Wockhardt	Acutaas Chemicals	Rubicon Research
Cash From Operating Activities	-1.57	1,652.60	390.00	292.17	205.05
Cash Flow from Investing Activities	1.65	-826.03	-241.00	-265.94	-409.72
Cash from Financing Activities	--	-38.98	-54.00	4.10	283.07
Net Cash Inflow / Outflow	0.09	787.59	95.00	30.33	78.39

	Transchem	Piramal Pharma	Wockhardt	Acutaas Chemicals	Rubicon Research
ROCE (%)	6.89	1.24	6.79	32.42	29.22
ROE (%)	5.61	-2.55	7.91	25.02	24.02
ROA (%)	5.62	-1.56	4.65	22.40	14.30
EBIT Margin (%)	--	3.19	14.37	36.50	21.09
Net Margin (%)	53.71	-2.71	10.48	27.16	15.36
Cash Profit Margin (%)	--	0.00	0.00	0.00	0.00

	Transchem	Piramal Pharma	Wockhardt	Acutaas Chemicals	Rubicon Research
Revenue Growth (%)	-100.00	9.43	25.70	45.18	46.25
EBIT Growth (%)	-143.15	-3.72	139.56	115.51	60.95
Net Profit Growth (%)	112.87	-199.34	894.12	95.80	89.41
EPS Growth (%)	112.87	-410.28	599.72	63.29	76.32
Book Value Growth (%)	5.37	0.33	13.47	26.03	144.31

	Transchem	Piramal Pharma	Wockhardt	Acutaas Chemicals	Rubicon Research
Price / Earnings	62.72	-157.53	81.64	73.25	88.08
Price / Book Value	2.48	4.02	6.32	17.32	20.24
Dividend Yield (%)	0.00	0.00	0.00	0.06	0.09
EV/EBITDA	-105.53	30.74	44.43	51.30	57.16
Market Cap (₹ Cr)	--	18,108.89	19,071.62	20,944.75	12,753.19

	Transchem	Piramal Pharma	Wockhardt	Acutaas Chemicals	Rubicon Research
Debt to Equity	0.00	0.55	0.28	0.02	0.13
Short term debt to equity ratio	--	0.09	0.09	0.00	0.05
Current Ratio	177.32	1.41	1.55	3.99	1.83
Quick Ratio	177.32	0.77	1.00	2.89	1.00
Interest Coverage	657.38	0.89	3.04	143.52	11.20

	Transchem	Piramal Pharma	Wockhardt	Acutaas Chemicals	Rubicon Research
Debtors to sales (%)	--	23.05	16.85	22.50	27.51
Asset Turnover	0.00	0.56	0.43	0.81	0.92
Receivable days	--	78.20	58.75	88.98	40.13
Inventory Days	--	93.30	75.82	56.04	60.29
Payable days	--	226.14	186.21	99.95	232.47
Cash Conversion Cycle	--	-54.64	-51.64	45.07	-132.04

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.